Search research articles
Contact Us
Filters
Showing results (1-10 of 7) with videos related to
Page
of 1
Sort By:
Advanced Drug Delivery Reviews
|
October 4, 2016
The immune system of the gut and potential adverse effects of oral nanocarriers on its function
Erik Őrfi, János Szebeni
Biomedicines
|
July 27, 2022
The Hypertensive Effect of Amphotericin B-Containing Liposomes (Abelcet) in Mice: Dissecting the Roles of C3a and C5a Anaphylatoxins, Macrophages and Thromboxane
Erik Őrfi, László Hricisák, László Dézsi, et al.
Molecules (Basel, Switzerland)
|
September 12, 2019
Complement Activation-Related Pathophysiological Changes in Anesthetized Rats: Activator-Dependent Variations of Symptoms and Mediators of Pseudoallergy
László Dézsi, Tamás Mészáros, Erik Őrfi, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
February 7, 2021
Complement-mediated hypersensitivity reactions to an amphotericin B-containing lipid complex (Abelcet) in pediatric patients and anesthetized rats: Benefits of slow infusion
Gergely Milosevits, Tamás Mészáros, Erik Őrfi, et al.
International Journal of Nanomedicine
|
March 19, 2019
Acute physiological changes caused by complement activators and amphotericin B-containing liposomes in mice
Erik Őrfi, Tamás Mészáros, Mark Hennies, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 24, 2014
Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: comparison of the porcine and rat responses
László Dézsi, Tamás Fülöp, Tamás Mészáros, et al.
International Journal of Nanomedicine
|
August 4, 2017
Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging
Harald Unterweger, Christina Janko, Marc Schwarz, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 7) with videos related to
Sort By:
Page
of 1
Advanced Drug Delivery Reviews
|
October 4, 2016
The immune system of the gut and potential adverse effects of oral nanocarriers on its function
Erik Őrfi, János Szebeni
Biomedicines
|
July 27, 2022
The Hypertensive Effect of Amphotericin B-Containing Liposomes (Abelcet) in Mice: Dissecting the Roles of C3a and C5a Anaphylatoxins, Macrophages and Thromboxane
Erik Őrfi, László Hricisák, László Dézsi, et al.
Molecules (Basel, Switzerland)
|
September 12, 2019
Complement Activation-Related Pathophysiological Changes in Anesthetized Rats: Activator-Dependent Variations of Symptoms and Mediators of Pseudoallergy
László Dézsi, Tamás Mészáros, Erik Őrfi, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine
|
February 7, 2021
Complement-mediated hypersensitivity reactions to an amphotericin B-containing lipid complex (Abelcet) in pediatric patients and anesthetized rats: Benefits of slow infusion
Gergely Milosevits, Tamás Mészáros, Erik Őrfi, et al.
International Journal of Nanomedicine
|
March 19, 2019
Acute physiological changes caused by complement activators and amphotericin B-containing liposomes in mice
Erik Őrfi, Tamás Mészáros, Mark Hennies, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
August 24, 2014
Features of complement activation-related pseudoallergy to liposomes with different surface charge and PEGylation: comparison of the porcine and rat responses
László Dézsi, Tamás Fülöp, Tamás Mészáros, et al.
International Journal of Nanomedicine
|
August 4, 2017
Non-immunogenic dextran-coated superparamagnetic iron oxide nanoparticles: a biocompatible, size-tunable contrast agent for magnetic resonance imaging
Harald Unterweger, Christina Janko, Marc Schwarz, et al.
Page
of 1